NEW YORK — The HudsonAlpha Institute for Biotechnology said on Monday that one of its postdoctoral researchers has won a $118,335 grant from the National Institutes of Health to continue research into the genetics of Alzheimer's disease.
With the funding, Nicholas Cochran — a senior postdoc in the lab of HudsonAlpha's Richard Myers — aims to study the regulation of the gene that encodes tau, a protein that is abnormally hyperphosphorylated and aggregates in the brains of Alzheimer's disease patients, and how it is influenced by rare variants.
The grant was awarded under the NIH Pathway to Independence program, which aims to help postdocs transition from mentored research to independent positions.